PROCEPT BioRobotics Corporation Investment Income, Interest
PROCEPT BioRobotics Corporation (PRCT) reported Investment Income, Interest of $12.22 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-02-26
- PROCEPT BioRobotics Corporation investment income, interest for the quarter ending 2022-03-31 was $36.00K, a 157.14% increase year-over-year.
- PROCEPT BioRobotics Corporation investment income, interest for the quarter ending 2021-12-31 was $27.00K, a 17.39% increase year-over-year.
- PROCEPT BioRobotics Corporation investment income, interest for the quarter ending 2021-09-30 was $22.00K, a 4.35% decline year-over-year.
- PROCEPT BioRobotics Corporation investment income, interest for the quarter ending 2021-03-31 was $14.00K.
- PROCEPT BioRobotics Corporation investment income, interest for fiscal 2025 was $12.22M, a 12.15% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation investment income, interest for fiscal 2024 was $10.89M, a 44.29% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation investment income, interest for fiscal 2023 was $7.55M, a 202.40% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation investment income, interest for fiscal 2022 was $2.50M, a 3185.53% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.22M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $10.89M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $7.55M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $2.50M 10-K · filed 2025-02-27 | |||
| 2022-03-31 | $36.00K 10-Q · filed 2022-05-06 | $63.00K derived: sum of 2 quarters · filed 2024-02-28 | $85.00K derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $49.00K derived: sum of 2 quarters · filed 2024-02-28 | $76.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $22.00K 10-Q · filed 2021-11-05 | $49.00K 10-Q · filed 2021-11-05 | ||
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-06 | $37.00K derived: sum of 2 quarters · filed 2022-05-06 | $60.00K derived: sum of 3 quarters · filed 2022-05-06 | |
| 2020-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $46.00K derived: sum of 2 quarters · filed 2022-03-22 | $184.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $23.00K 10-Q · filed 2021-11-05 | $161.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |